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Abstract
Diabetes mellitus (DM) is a chronic systemic disease characterized by hyperglycemia, with various patho-
genic mechanisms. From absolute or relative insulin deficiency, patients with DM often demonstrate vari-
ous levels of metabolic disorders. Major clinical manifestations of DM include metabolic disorders, vascu-
lar lesions, circulatory disturbances and neurologic complications. Along with advances in DM research, re-
ports of DM related tinnitus and hearing impairment have increased continuously. Research on DM related
auditory system dysfunction has focused on cochlear microcirculation, cellular homeostasis, genetics and ag-
ing. Cochlear microcirculation plays an important role in cochlear physiology and its disorders are associat-
ed with many inner ear diseases. Ischemia and subsequent reperfusion seen in cochlear microcirculation dis-
orders are important factors in hearing damage. Understanding cochlear microcirculation and structural as
well as functional changes in DM patients with hearing loss and their causal factors will help reveal patho-
genic mechanisms in diabetic hearing loss and provide new ideas in developing interventions and preventing
damages caused by diabetes.
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Introduction
Studies have since long indicated a close relation be-
tween diabetes mellitus (DM) and hearing loss [1,2]. The
main clinical manifestation of DM is glucose, lipid and
protein metabolism disorders, for the body is unable to
produce or use insulin properly[3]. Metabolic disorders in
DM include decreased lipid synthesis and increased lipid
breakdown, which lead to elevated blood lipid levels and
contribute to arthrosclerosis. With sustained high levels
of blood glucose, increased amount of glycated hemoglo-
bin is produced and deposited in the walls of small blood
vessels. Together with injury to the endothelium by im-
mune complex, this leads to increased vessel permeabili-
ty, thickened basement membrane and abnormal growth
of endothelial cells, resulting in reduced lumen size.
With constricted or blocked supplying vessels and sus-
tained high glucose levels, nerves become malnourished
and their cellular membrane demonstrate dysplasia or ne-
crosis changes from metabolic disorders, leading to the
so called diabetic peripheral neuropathy which can also
involve the autonomous nerves and can happen at an ear-
ly stage of diabetes. Microcirculation disorders and he-
modynamic changes (including that in the cochlea) are
common in DM[4], which can also contribute to diabetic
neuropathy. Involvement of the immune system has also
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been shown to be an important etiology and mechanism
of DM and its complications. In addition to systemic ef-
fects, there have been increasing reports of compromised
inner ear functions in DM, including dizziness, tinnitus
and hearing loss. Along with advances in research on
DM and its complications, there has been an increasing
attention to hearing disorders in patients with DM[5].
Studies have indicated that vascular and neural changes
in the cochlea are likely the cause of hearing changes in
DM, including thickening of capillary walls (especially
in the stria vascularis) and loss of outer hair cells[6].
Blood vessels supplying the cochlea carry no collateral
circulation once inside the cochlea. Cochlear microcircu-
lation provides the cochlea with energy and substrates,
carries away metabolic wastes, and helps maintain co-
chlear homeostasis. The functions of the inner ear de-
pend on the stability of its internal environment support-
ed by microcirculation. While it is clear that compro-
mised cochlear blood supply can lead to cochlear dys-
function[7-9], details of injury mechanisms in diabetic hear-
ing loss such as regulation of cellular transduction sig-
nals and neural, humoral and autonomous regulation of
microcirculation are subject to debate and yet to be thor-
oughly studied. This paper aims at reviewing and sum-
marizing existing literature on DM-related inner ear dis-
orders, as well as discussing their possible etiology and
pathogenesis.
Effects of DM on the audiotry system
Cochlear microcirculation plays a very important role
in cochlear physiology. Hyperglycemia and hyperlipid-
emia are associated with increased blood viscosity and
circulation disorders. Studies have indicated that inner
ear diseases are often associated with microcirculation
disorders, especially involving the stria vascularis. The
associated tissue ischemia and hypoxia can cause dam-
age to single or multiple neural units and/or hair cells.
The deep location and complex structures of the inner
ear makes its morphological studies difficult. Research
on cochlear microcirculation therefore lacks behind mi-
crocirculation studies of other organs, despite research-
ers’efforts and some recent advances. Lipid metabolic
disorders can lead to lipid deposit in cochlear hair cells
and damage of cochlear neural cells, followed by imped-
ed neural transduction. The high dependence on glucose
as the source for its high energy consumption makes the
cochlea a target of damage in DM.
Basic research on DM effects on the audi-
tory system
The labyrinthine artery comes from the basal artery
or from the anterior inferior cerebellar artery. Labyrin-
thine artery gives rise to the common cochlear artery and
vestibular artery, the former giving rise to the vestibulo-
cochlear artery and spiral modiolar artery that supply the
cochlea [10]. Blood pressure can affect cochlear microcir-
culation[11], although the correlation between cochlear
blood flow and systemic blood pressure is relatively
weak. It is believed that there is an autonomous regula-
tion mechanism in cochlear microcirculation, although it
is not as obvious as that with cerebral blood flow. Such
regulation has not been seen in muscles[12]. Autonomous
regulation in cochlear microcirculation refers to a local
regulatory activity within the cochlear micro vessels and
is an important factor in maintaining normal cochlear
blood supply. Among the multiple complex regulatory
mechanisms of cochlear blood flow, the local regulation
of cochlear micro vessels plays an important role. Stud-
ies show that lateral cochlear wall micro blood vessels are
not fully open under normal circumstances but open in
alteration, indicating certain levels of reserve in blood [13].
Regulation of cochlear blood vessels is dominated by lo-
cal metabolites. The responsiveness of endothelial cells
is critical in local vessel changes, although neural con-
trol is also at play[14]. Auto-rhythmic activities have been
observed with normal arterioles in the cochlea. L-argi-
nine significantly increases the frequency and magnitude
of these activities and may enhance cochlear microcircu-
lation and increase cochlear blood flow[15]. Study evi-
dence indicates that regulation of blood flow in cochlear
lateral wall relies on the tropomyosin-like immune ac-
tive materials near the endothelial and peripheral cells in
the spiral ligament, supporting the notion that there are
active local regulatory materials in cochlear micro blood
vessels[16]. Under certain pressure or anoxic conditions,
endothelium releases ATP, acetylcholine and endothelin,
which, upon interacting with their receptors, produce an
endothelium-dependent factor, now called nitric oxide,
which causes smooth muscle relaxation[17].
Cochlear microcirculation changes with age. In 1990,
Prazma[18] reported greatly decreased cochlear blood flow
in old gerbils, especially in the lateral stria vascularis. In
2000, Seidman[19] showed in Fischer rats that blood flow
slowed or was blocked as the animal aged, resulting in
insufficient local perfusion and cochlear microcircula-
tion dysfunction, followed by cochlear and vestibular
malfunctions.
Cochlear microcirculation changes have also been re-
ported in pathological conditions. Masutani[20] found de-
creased blood vessels in the stria vascularis and correlat-
ed stria vascularis atrophy under Meniere’s disease con-
dition. DM can also change cochlear microcirculation.
In 2006, Wang[21] reported changes in ultrastructure of in-
ner ear capillaries in a rat model of DM, including thick-
ened basement membrane. In 2000, Tomisawa[22] com-
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pared temporal bone stria vascularis sections from 16
DM patients with those from 16 non-DM patients and
found atrophy and thickening changes. He concluded
that capillary lumen changes from basement membrane
thickening and atrophy of the stria vascularis are impor-
tant factors in hearing loss in DM patients.
In addition to changes in the vascular structures, other
morphological changes in the inner ear in DM have also
been reported. In rats, DM was reported to cause patho-
logical changes in outer hair cells (OHCs), spiral gangli-
on cells and nerve fibers, primarily mitochondria damag-
es[23]. When compounded with noise exposure at 95 dB
SPL, significantly increased OHC loss was found in rats
with streptozotocin-induced diabetes as compared to nor-
mal controls[24]. Other diabetes-related metabolic disor-
ders can also result in morphological abnormalities in
the cochlea. Lipid metabolism disorders have been
found to lead to deposit of fatty droplets in hair cells and
are thought to be a direct cause of deafness in DM, with
microvascular changes having probably a secondary in-
fluence on inner ear functioning and spiral ganglion dys-
plasia being a subsequent change[25]. In fact, high fre-
quency hearing loss and increased susceptibility to noise
damage have been reported in mice on high cholesterol
diet, with hyperlipidemia and vascular abnormalities be-
ing blamed as the cause[26].
One important consequence of cochlear microvascular
and morphological changes is auditory dysfunction. In
middle aged and old mice, increased auditory brainstem
response (ABR) thresholds were found to be associated
with type I and, especially, type II DM modeling, with de-
creased distortion product otoacoustic emission (DPOAE)
amplitudes[27]. The latency of ABR wave I was found to
be delayed in gerbils with high sugar diet induced diabe-
tes, although without changes in amplitudes[28]. Changes
in otoacoustic emissions (OAEs) were found to take place
before abnormal ABRs in a rat DM model, with oxida-
tion injury to the OHC related to inner ear damage and
metabolic disorders blamed as the underlying cause [29].
Clinical studies on diabetes-related hear-
ing impairment
Along with advances in DM research, hearing func-
tion in DM patients has attracted increasing attention
from clinicians including audiologists, with increasing re-
ports on DM related hearing damage. It has been report-
ed that prevalence of hearing loss in DM patients is
twice that in normal individuals and that vertigo, tinnitus
and hearing loss in DM patients are likely from inner ear
diseases related to glucose metabolism disorders[30]. Sus-
ceptibility to hair cell damage and hearing loss in noise
exposure has been found to be increased in insulin depen-
dent DM, probably related to dysplasia changes in the in-
ner ear[31]. Research shows that hearing loss in most DM
patients has little to do with noise exposure, can take
place gradually or suddenly, and is usually high frequen-
cy sensorineural loss. Many patients may not realize the
relation between their hearing impairment and their dia-
betic condition. Clinicians (especially endocrinologists)
therefore need to monitor hearing in DM patients, in ad-
dition to other common diabetic complications, to ensure
timely interventions.
In as early as 1975, Friedman[32] evaluated hearing in
20 DM patients with peripheral neuropathy and showed
that hearing thresholds were elevated in at least one fre-
quency in 11 of these patients (55%), higher than normal
individuals of the same age. Snashall proposed in 1977
that DM might lead to premature hearing deterioration [33].
Sieger (1983) compared pure tone audiometry and ABRs
between 51 insulin dependent DM patients and 13
non-DM patients and found no difference, although in-
sufficient sensitivity of testing methodology was thought
to be the reason[34]. In 1989, Kurien found that average
hearing thresholds in 30 DM patients younger than 50
years were worse than those in 30 non-DM patients[35].
In 1993, Cullen[36] compared hearing in 44 insulin depen-
dent DM patients with 38 healthy individuals and found
hearing was worse in DM patients, especially in males,
which was not affected by dose of insulin or family histo-
ry. A study by Tay in 1995[37] that compared 102 DM pa-
tients with 102 healthy individuals demonstrated signifi-
cantly deteriorated mid and low frequency hearing in
DM patients that seemed to be correlated with disease
duration but not with stages of retinopathy. Similar rela-
tion between hearing impairment and DM duration was
also shown in a study by Lasisi in 2003[38], in which bone
conduction thresholds in 13 DM patients were higher
than non DM patients and correlated to DM duration, es-
pecially in those longer than 10 years. Based upon evalu-
ation, including hearing assessment, of 59 DM patients
with retinal and nephritic complications in comparison
to 20 DM patients without complications, Bayazit[39] con-
cluded that diabetic peripheral neuropathy and encepha-
lopathy are the cause of sensorineural hearing loss in
DM. Zhao[40] showed significantly worse hearing thresh-
olds in 50 DM patients (type II = 46, type I = 4) with
complications compared to those without complications,
and concluded that mechanisms of diabetic hearing loss
are the same for other diabetic complications and that
treatment should focus on controlling diabetic complica-
tions. In 2008, Loader found significant differences in
pure tone audiometry results between DM patients and
normal individuals at all frequencies and believed that
cochlear microvascular as the cause of hearing impair-
ment should be further studied[41].
In addition to audiometry, other test modalities have al-
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so been used to study effects of DM on the auditory sys-
tem. In 1990, Parving[42] found that, in a group of 20 insu-
lin dependent DM patients, ABRs were abnormal in 40%
of those with long disease history, suggesting possible
presence of diabetic encephalopathy. In 1998, Wang[43]
tested DPOAEs in 19 patients with well controlled DM
and 19 normal adults and found that DPOAEs might re-
veal early stage mild damage and dysfunction in the co-
chlea and efferent nervous system and might be useful for
early diagnosis of diabetic hearing impairment. Orts[44]
studied DPOAEs in 20 insulin dependent DM patients in
1998 and concluded that diabetic cochlear diseases might
be related to OHC injury. Lisowska[45] compared DPOAEs
between 42 young and middle aged insulin dependent
DM patients and 33 age/gender matched non DM patients
and found reduced DPOAE amplitudes among the DM pa-
tients. It was concluded that OHC injury might be respon-
sible for early stage diabetic hearing impairment. In
2002, Ottaviani[46] studied OAEs in 60 type I DM patients
and 58 normal volunteers and found that OAEs were ei-
ther unilaterally or bilaterally absent in some diabetic pa-
tients. Reproducibility and magnitudes of OAEs across
speech frequencies (1-4 kHz) were reduced compared to
normal volunteers. The authors concluded that OAEs
might be useful in detecting early stage cochlear damage.
Zhang[47] found that latencies of ABR waves III and V and
I-III and III-V interwave latencies were delayed in 50 DM
patients compared to 50 healthy individuals, indicating in-
creased transduction time from the brainstem to the mid
brain. In another study in 2005, Diaz[48] tested pure tone
and speech audiometry and ABRs in 92 patients with type
II DM in comparison to 94 age and gender matched
healthy subjects and identified subclinical hearing loss
and impaired ABRs in the diabetic patients which ap-
peared to increase with age.
Other potential pathogenic factors in diabetic hearing
loss in human have also been studied. Gutmanns in1993[49]
analyzed ultrasound results from 150 patients with verti-
go, hearing loss and tinnitus and identified arterial diseas-
es of various degrees, suggesting early stage cerebral
ischemia. In 2002, Callejo[50] found significantly in-
creased blood viscosity and erythrocyte adhesion in DM
patients with hearing loss compared to normal hearing in-
dividuals. Niiya[51] studied effects of age factor on
up-regulation of thrombocianase in the aortic endothelial
cells in 29 diabetic patients in comparison to 19 healthy
individuals. The results showed that up-regulation in en-
dothelial cells of cerebral microvessels was more affect-
ed by the age factor and there were increased levels of
radical oxidation species (ROS) in these endothelial
cells. In the same year, Fukushima[52] conducted a mor-
phological study in 18 patients with type II DM who
were randomly selected to receive insulin (n=11) or oral
anti-diabetic agents (n=7) in comparison to 26 normal
controls. The results indicated that microvascular chang-
es were likely the main mechanisms in diabetic hearing
loss. Such changes included disorders in the cochlear
micro vessels, dysplasia of the stria vascularis and of co-
chlear OHCs. Microcirculation disorders as a mecha-
nism in diabetic hearing loss is also supported by serolo-
gy studies. Serum creatinine is found to be elevated in
diabetic patients with hearing loss as compared to non di-
abetic patients and correlated to the degree of hearing
loss and blood glucose levels[53, 54]. In addition to comor-
bid vascular diseases, and probably associated with endo-
thelial cell injury, platelet activation, enhanced coagulat-
ing factor activities and reduced fibronolytic system
function have also been reported in patients with type II
DM, indicating their potential values in early diagnosis
of diabetic hearing loss and comorbid vascular diseases [55].
DM has been suspected to be a hereditary condition.
DM patients may carry related genes at the time of birth.
The interaction of these genetic factors with other envi-
ronmental factors may eventually lead to clinical DM
manifestation. Mitochondria DNA mutations have been
identified in patients with maternally inherited DM and
hearing loss. mDNA mutations can affect mitochondrial
functions, leading to inner ear structural and functional
changes and hearing loss.
Potential significances of such reseach
in management of diabetic hearing loss
Microcirculation disorders are important pathological
basis in diabetic hearing loss and hemodynamic changes
are important indicators of microcirculation. Improving
microcirculation is therefore an important approach in
treating related hearing loss. Lin[56] studied the effects of
atrial natriuretic factor (ANF) on cochlear microcircula-
tion in guinea pigs and found that, despite lowering sys-
temic blood pressure, ANF effectively increased cochle-
ar blood flow when given intravenously in a dose-depen-
dent fashion. Jiang[57] separated and cultured cochlear cells
in neonatal SD rats to examine cell proliferation with
5-bromine-2-deoxyuracil and to determine cell differenti-
ation via immunofluorence. Results indicated that there
were proliferative cells in neonatal rat cochlea, which
were able to differentiate in vitro into cells with hair cell
or neuron markers. This may provide a new approach in
treating sensorineural hearing loss using cell transplanta-
tion. Liu[58] studied expression of nerve growth factor
(NGF) and its changes in the cochlea in rapidly aging
mice using immunohistochemical methodology. The
findings showed that NGF was expressed in mouse co-
chleae and the expression levels decreased as the mice
aged, indicating its role in maintaining cochlear functions
and possible application in treating cochlear hearing loss.
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Summary
DM is closely linked to hearing damage. Both large
and microscopic size blood vessels are affected in DM.
Metabolic disorders, atherosclerotic changes and micro
vessel diseases result in ischemia and hypoxia in neural
tissues, leading to nerve damage. When such pathologi-
cal changes involve the cochlea and auditory nerve, co-
chlear and/or neural hearing loss follows. Due to the of-
ten high frequency nature of DM related hearing loss, it
commonly goes undetected and unreported. A hearing
monitoring approach is therefore important clinically. In-
terventions aimed at controlling factors that may cause
morphological and functional changes in the cochlea are
critical in managing diabetic hearing damage. Further
studies are needed to develop effective treatment for in-
ner ear diseases caused by cochlear microcirculation dis-
orders related to DM.
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